Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent GBM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT03360708
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Giant Cell GlioblastomaRecurrent GlioblastomaRecurrent Gliosarcoma
Mayo Clinic 20
Testing effectiveness (Phase 2)WithdrawnNCT05879120
What this trial is testing

Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02521090
What this trial is testing

EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma

Who this might be right for
Adult Brain GlioblastomaAdult GliosarcomaRecurrent Brain Neoplasm
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT04201873
What this trial is testing

Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Jonsson Comprehensive Cancer Center 46
Testing effectiveness (Phase 2)Temporarily pausedNCT06325683
What this trial is testing

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Progressive GlioblastomaRecurrent Glioblastoma
National Cancer Institute (NCI) 184
Testing effectiveness (Phase 2)Study completedNCT00293423
What this trial is testing

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 96
Testing effectiveness (Phase 2)Study completedNCT01268566
What this trial is testing

MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
MedImmune LLC 62
Early research (Phase 1)Study completedNCT02709226
What this trial is testing

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Temporarily pausedNCT01933815
What this trial is testing

Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Cortice Biosciences, Inc. 92
Testing effectiveness (Phase 2)Study completedNCT00501891
What this trial is testing

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma Multiforme
Duke University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06558214
What this trial is testing

OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial

Who this might be right for
Recurrent Glioblastoma
University of Florida 20
Very early researchNot Yet RecruitingNCT06691308
What this trial is testing

WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients

Who this might be right for
Recurrent or Progressive Glioblastoma
Beijing Immunochina Medical Science & Technology Co., Ltd. 6
Early research (Phase 1)Study completedNCT01048008
What this trial is testing

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer

Who this might be right for
Advanced CancerBrain Involvement
DEKK-TEC, Inc. 22
Testing effectiveness (Phase 2)WithdrawnNCT01782976
What this trial is testing

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00629889
What this trial is testing

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsSeizure
Dr Andrea Rossetti 52
Not applicableNo Longer AvailableNCT03068650
What this trial is testing

Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut

Who this might be right for
Recurrent GBM
Celldex Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00597493
What this trial is testing

Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM

Who this might be right for
Recurrent Glioblastoma Multiforme
Duke University 32
Early research (Phase 1)Study completedNCT00014521
What this trial is testing

Karenitecin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT02852655
What this trial is testing

A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma

Who this might be right for
Brain Cancer
Dana-Farber Cancer Institute 60
Next Page